Jan Endell
11Patents
3h-index
9Co-inventors
49Inventor score
Filing activity: Sep 26, 2011 → Dec 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8877899B2 | Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL | Chemistry; Metallurgy | 13 | Active |
| US9289490B2 | Combinations and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9579378B2 | Combinations and uses thereof | Human Necessities | 3 | Active |
| US10617691B2 | Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9765152B2 | Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib | Chemistry; Metallurgy | 1 | Active |
| US10533057B2 | Treatment for multiple myeloma (MM) | Chemistry; Metallurgy | 1 | Active |
| US11224654B2 | Combinations and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11591406B2 | Treatment for multiple myeloma (MM) | Chemistry; Metallurgy | 0 | Active |
| US10308722B2 | Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide | Chemistry; Metallurgy | 0 | Active |
| US12358983B2 | Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof | Human Necessities | 0 | Active |
| US12194095B2 | Combinations and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.